Toxoplasmosis News and Research

RSS
Toxoplasmosis is considered to be the third leading cause of death attributed to foodborne illness in the United States. More than 60 million men, women, and children in the U.S. carry the Toxoplasma parasite, but very few have symptoms because the immune system usually keeps the parasite from causing illness. However, women newly infected with Toxoplasma during pregnancy and anyone with a compromised immune system should be aware that toxoplasmosis can have severe consequences for them.
Study estimates disease burden of congenital toxoplasmosis in Denmark

Study estimates disease burden of congenital toxoplasmosis in Denmark

Study uncovers potential new therapeutic targets for HCV infections

Study uncovers potential new therapeutic targets for HCV infections

Parasite's biological clock could help improve treatments for deadly sleeping sickness

Parasite's biological clock could help improve treatments for deadly sleeping sickness

Scientists develop new molecular method for detecting parasite in ham that causes toxoplasmosis

Scientists develop new molecular method for detecting parasite in ham that causes toxoplasmosis

Study provides important insights into impact of late HIV testing

Study provides important insights into impact of late HIV testing

First case-control study examines link between microcephaly and in utero Zika virus infection

First case-control study examines link between microcephaly and in utero Zika virus infection

Malformations in the brains of fetuses caused by Zika virus go beyond microcephaly

Malformations in the brains of fetuses caused by Zika virus go beyond microcephaly

GW researchers identify new way to regulate chronic toxoplasmosis

GW researchers identify new way to regulate chronic toxoplasmosis

Griffith researchers create Malaria Box to advance drug discovery for major topical diseases

Griffith researchers create Malaria Box to advance drug discovery for major topical diseases

Findings offer renewed hope for speedy development curative medicines for people with toxoplasmosis

Findings offer renewed hope for speedy development curative medicines for people with toxoplasmosis

Preventing zoonotic diseases from pets to people: an interview with Dr Monique Éloit, OIE Director General

Preventing zoonotic diseases from pets to people: an interview with Dr Monique Éloit, OIE Director General

Study explores anti-Toxoplasma effects of estragole and thymol compounds

Study explores anti-Toxoplasma effects of estragole and thymol compounds

GMU’s early-detection urine test works for Lyme disease, study shows

GMU’s early-detection urine test works for Lyme disease, study shows

Candida yeast infections more common in men with schizophrenia or bipolar disorder

Candida yeast infections more common in men with schizophrenia or bipolar disorder

Common parasitic infection linked to intermittent explosive disorder

Common parasitic infection linked to intermittent explosive disorder

Toxoplasmosis infection may be linked to rage disorder

Toxoplasmosis infection may be linked to rage disorder

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Study identifies potential new approaches to curing parasitic diseases

Study identifies potential new approaches to curing parasitic diseases

New research may offer strategies for developing toxoplasma-inactivated vaccine

New research may offer strategies for developing toxoplasma-inactivated vaccine

Basic research for developing toxoplasma vaccine underway

Basic research for developing toxoplasma vaccine underway

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.